Effient Information and Warnings

As the results of a new study on the blood-thinning drug Effient recently became publicized, researchers have called for a warning to be placed on Effient labels. The study suggests that Effient users are at a high risk of developing new or worsened cancer tumors. The researchers believe that Effient may promote cancer growth because one of its side effects is that it inhibits the body’s natural tumor-blocking defenses.

The FDA approved Effient for use by angioplasty patients in July 2009. At that time, the FDA mandated a warning on Effient boxes that alerted doctors that Effient could cause significant and sometimes fatal bleeding in patients with active pathological bleeding, a history of mini-strokes, or who were in urgent need of surgery, including coronary artery bypass graft surgery.

In response to the recent studies showing a link between Effient use and cancer, the FDA did its own research and found evidence to support the increase in cancer tumors among Effient patients. However, the FDA has yet to issue a warning concerning the potential cancer risk of using Effient.

If you or a loved one has been harmed by the use of the blood-thinner Effient, you have rights. You should seek the help of an experienced Effient attorney to protect those rights. A time limit in your state known as the statute of limitations applies to all potential lawsuits, and if you don’t file in time, you will lose your right to recover.

Check out the following articles for more information about Effient, filing an Effient lawsuit, and finding an Effient attorney.